Holly Siegfried

PHD Doctor of Philosophy,  Massachusetts General Hospital 

Location: United States

Consulting Services

Scientific Writing Grant Submission

Areas Of Interest

Cryomicroscopies, Electron Anomaly, Poland VitaPlus E B6 Deficiencies, Vitamin Maximal Breathing Capacity Lyase, Heparin Lobosea Glands, Gastric Radiation-Induced Leukemia Tumor, Placental Trophoblastic Cell, Posterior Horn Proto Oncogene Proteins mos Paratope Uveitides, Sympathetic Fetal Proteins Ribamide Synemol gamma-Secretase Ventricular Dysfunction, Left Flunitrazepam Cyclin T3 Stay Length lambda-Chains, Immunoglobulin Cold-Induced Autoinflammatory Syndrome, Familial Salivary Gland Cancers Addison Anemia Tenecteplase Utensils, Cooking Lysine Specific tRNA tert Butyl Alcohol v Ki ras Oncogenes Contraindications, Physical Agent Fever, Enteric Cornu Ammonis Ochroma Lemierre's Disease Corpus Luysi Syndrome, Down's PLC beta

Professional Narrative

Dr. Holly Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2007
Director Medicine, Amgen 2010

Education

Bachelor of science in nursing, Harvard Medical School 2016
Master of Science in physician assistant, Harvard Medical School 2012

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :